GENE ONLINE|News &
Opinion
Blog

Bispecific Antibody
News Flash Sanofi
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
ASCO 2024 ASCO Previews
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
Partnerships Takeda PharmaceuticalF-starBispecific Antibody
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Licensing Bispecific Antibody
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Licensing Bispecific Antibody
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
Partnerships Bispecific Antibody
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
Partnerships Regeneron
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Trials & Approvals Multiple Myeloma
Janssen Scores Another Multiple Myeloma FDA Approval with Tecvayli
2022-10-25
Partnerships Bispecific Antibody
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
Trials & Approvals Follicular Lymphoma
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Asia-Pacific Sanofi
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
M&A SanofiBispecific AntibodyT-cell Activation
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
Feature Blood CancerCancer Immunotherapy
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
Licensing Cancer Immunotherapy
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Special Cancer Immunotherapy
Bispecific Antibodies or CAR T-Cells: Which One of These Cancer Immunotherapies Would Prevail?
2021-09-29
1 2
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
READ MORE
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top